Copyright
©The Author(s) 2016.
World J Gastroenterol. Aug 14, 2016; 22(30): 6925-6935
Published online Aug 14, 2016. doi: 10.3748/wjg.v22.i30.6925
Published online Aug 14, 2016. doi: 10.3748/wjg.v22.i30.6925
Figure 1 Immunohistochemistry of the spleen for CD20+ B-cell follicles and CD 138+ plasma cells.
Reduced size of B-cell follicles after rituximab prophylaxis in the spleen (A) compared to a control (B) (× 40). Plasma cells in the spleen with rituximab prophylaxis (C) and without (D) (× 400).
- Citation: Bang JB, Kim BW, Kim YB, Wang HJ, Lee HY, Sim J, Kim T, Lee KL, Hu XG, Mao W. Risk factor for ischemic-type biliary lesion after ABO-incompatible living donor liver transplantation. World J Gastroenterol 2016; 22(30): 6925-6935
- URL: https://www.wjgnet.com/1007-9327/full/v22/i30/6925.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i30.6925